CONMED Corporation (CNMD) News

CONMED Corporation (CNMD): $80.49

-1.61 (-1.96%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter CNMD News Items

CNMD News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

CNMD News Highlights

  • For CNMD, its 30 day story count is now at 2.
  • Over the past 15 days, the trend for CNMD's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about CNMD are PDCO.

Latest CNMD News From Around the Web

Below are the latest news stories about CONMED CORP that investors may wish to consider to help them evaluate CNMD as an investment opportunity.

CONMED Corporation to Participate in a Fireside Chat at the Morgan Stanley Global Healthcare Conference

LARGO, Fla., September 06, 2022--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 20th Annual Morgan Stanley Global Healthcare Conference at 5:15 p.m. ET on Tuesday, September 13, 2022.

Yahoo | September 6, 2022

PDCO vs. CNMD: Which Stock Is the Better Value Option?

PDCO vs. CNMD: Which Stock Is the Better Value Option?

Yahoo | August 22, 2022

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

CONMED Corporation ( NYSE:CNMD ) has announced that it will pay a dividend of $0.20 per share on the 5th of October...

Yahoo | August 18, 2022

CONMED Corporation Announces Quarterly Cash Dividend

LARGO, Fla., August 11, 2022--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2022 to all shareholders of record as of September 15, 2022.

Yahoo | August 11, 2022

CONMED (CNMD) Acquires Soft Tissue Implant Start-Up Biorez

CONMED (CNMD) acquires privately-held Biorez, Inc. for $85 million. The deal is set to boost CONMED's sports medicine portfolio with the addition of Biorez's proprietary BioBrace Implant technology.

Yahoo | August 10, 2022

CONMED Completes Acquisition of Biorez, Inc.

LARGO, Fla., August 09, 2022--CONMED Corporation (NYSE: CNMD) today announced that it has completed its previously announced acquisition of privately-held Biorez, Inc.

Yahoo | August 9, 2022

PDCO vs. CNMD: Which Stock Should Value Investors Buy Now?

PDCO vs. CNMD: Which Stock Is the Better Value Option?

Yahoo | August 5, 2022

Conmed's New Acquisition Is 'Door-Opener' For Orthopedic Surgery Business, This Analyst Says

Earlier today, CONMED Corporation (NYSE: CNMD) agreed to acquire privately held Biorez Inc for $85 million and up to $165 million in commercial-based milestones. Biorez commercializes its BioBrace implant, a bioinductive scaffold used to reinforce soft tissue where weakness exists and promote soft tissue healing. Needham says that in the near term, Biorez is expected to be accretive to revenue growth and gross margins (Biorez's gross margin is >80% vs. CNMD's 2022E gross margin of ~55%). "In add

Yahoo | August 2, 2022

CONMED Announces Definitive Agreement to Acquire Biorez, Inc.

LARGO, Fla., August 01, 2022--CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately held Biorez, Inc. (Biorez), on a cash-free, debt-free basis, for cash consideration of $85 million at closing, subject to adjustment, and up to an additional $165 million in growth-based earnout payments over a four-year period. The transaction is expected to be financed through the company's existing credit facility. The transaction is expected to close in early August 2022.

Yahoo | August 1, 2022

CONMED (CNMD) Down on In-Line Q2 Earnings & Lower 2022 View

CONMED's (CNMD) adjusted second-quarter earnings reflect strong segmental performance. However, unfavorable currency movement hurt sales growth. Inflationary or supply chain challenges hurt gross margin.

Yahoo | July 28, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5672 seconds.